Pfs Partners, LLC Pro Qr Therapeutics N.V. Transaction History
Pfs Partners, LLC
- $199 Billion
- Q2 2025
A detailed history of Pfs Partners, LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Pfs Partners, LLC holds 1,000 shares of PRQR stock, worth $2,170. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$2,170
Previous $1.33 Million
53.38%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
68Shares Held
42MCall Options Held
30.1KPut Options Held
5.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.1MShares$17.6 Million0.02% of portfolio
-
Privium Fund Management B.V.5MShares$10.8 Million2.17% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.28MShares$7.13 Million0.49% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.07MShares$4.49 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.05MShares$4.46 Million1.03% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $155M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...